CACYBP anticorps (AA 1-185)

N° du produit ABIN5775925

L’anticorps Souris Monoclonal anti-CACYBP a été validé pour WB, ELISA, IF et ICC. Il convient pour détecter CACYBP dans des échantillons de Humain.

Aperçu rapide pour CACYBP anticorps (AA 1-185) (ABIN5775925)

Antigène: CACYBP (Calcyclin Binding Protein (CACYBP))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp CACYBP est non-conjugé

Application: Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunocytochemistry (ICC)

Clone: AT3G8

Détail du produit anti-CACYBP anticorps

Épitope: AA 1-185

Fonction: Human CACYBP antibody

Purification: Purified

Immunogène: Recombinant human CACYBP (1-185aa) purified from E. coli

Isotype: IgG2a kappa

Information d'application

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C,-80 °C

Stockage commentaire: Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.

Détails sur CACYBP

Antigène: CACYBP (Calcyclin Binding Protein (CACYBP))

Autre désignation: CACYBP

Sujet: CACYBP (Calcyclin-binding protein) is primarily a nuclear protein that contains one CS domain and one SGS domain. CACYBP is believed to be involved in calcium-dependent ubiquitination and subsequent proteosomal degradation of target proteins. It most likely serves as a molecular bridge in ubiquitin E3 complexes. It also participates in the ubiquitin-mediated degradation of b-catenin. CACYBP is thought to be a potential inhibitor of cell growth and invasion in the gastric cancer cell through its effects on b-catenin protein expression and transcriptional activation of TCF/LEF.

NCBI Accession: NP_001007215

Pathways: Response to Growth Hormone Stimulus